.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
US Army
Mallinckrodt
Baxter
Medtronic
Federal Trade Commission
Novartis
Merck
Boehringer Ingelheim

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020212

« Back to Dashboard

NDA 020212 describes ZINECARD, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. Additional details are available on the ZINECARD profile page.

The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.

Summary for 020212

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 020212

Medical Subject Heading (MeSH) Categories for 020212

Suppliers and Packaging for NDA: 020212

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212 NDA Pharmacia and Upjohn Company LLC 0013-8717 0013-8717-62 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-8717-62) > 25 mL in 1 VIAL, SINGLE-DOSE
ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212 NDA Pharmacia and Upjohn Company LLC 0013-8727 0013-8727-89 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-8727-89) > 50 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 250MG BASE/VIAL
Approval Date:May 26, 1995TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:May 26, 1995TE:APRLD:Yes

Expired Orange Book Patents for NDA: 020212

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
Pharmacia And UpjohnZINECARDdexrazoxane hydrochlorideINJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Colorcon
Accenture
Daiichi Sankyo
Dow
Julphar
McKesson
QuintilesIMS
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot